Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
RESEARCH TOOLSreports
Holding FDMT?
Track your performance easily
See the Price Targets and Ratings of:
FDMT Analyst Ratings
Moderate Buy
9 Buy
1 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
FDMT Stock 12 Month Forecast
Average Price Target
$47.00
▲(503.34% Upside)
| Highest Price Target$82.00 | Average Price Target$47.00 | Lowest Price Target$8.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgan Stanley
Initiated
11/21/24
Chardan Capital
Reiterated
11/14/24
Barclays
Reiterated
11/14/24
H.C. Wainwright
Reiterated
11/14/24
RBC Capital
Reiterated
11/14/24
Cantor Fitzgerald
Downgraded
09/23/24
Goldman Sachs
Reiterated
09/19/24
Bank of America Securities
Reiterated
09/19/24
Jefferies
Reiterated
09/18/24
BMO Capital
Assigned
09/18/24
Leerink Partners
$40→$36
Buy
362.13%
Upside
Reiterated
09/18/24
We nudge 4D-150 launch from 2028 to 2029 —to reflect staggered launch timing of 4FRONT studies and enrollment pace in the recently diagnosed and treatment-naïve wet AMD patients—reducing our PT from $40 to $36. Reit. OP.
Best Analysts Covering 4D Molecular Therapeutics
Which Analyst Should I Follow If I Want to Buy FDMT and Sell After:
1 Month
xxx
Success Rate
6/11 ratings generated profit
Average Return
+6.47%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 54.55% of your transactions generating a profit, with an average return of +6.47% per trade.
3 Months
xxx
Success Rate
6/11 ratings generated profit
Average Return
-0.16%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 54.55% of your transactions generating a profit, with an average return of -0.16% per trade.
1 Year
Success Rate
6/16 ratings generated profit
Average Return
-13.30%
reiterated a buy rating 10 days ago
Copying Matthew Caufield's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -13.30% per trade.
2 Years
xxx
Success Rate
1/11 ratings generated profit
Average Return
-43.68%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 9.09% of your transactions generating a profit, with an average return of -43.68% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
FDMT Analyst Recommendation Trends
Rating
Jun 24
Jul 24
Aug 24
Sep 24
Nov 24
Strong Buy
12
16
19
24
20
Buy
3
4
2
1
1
Hold
0
0
0
1
1
Sell
0
0
0
0
1
Strong Sell
0
0
0
0
0
total
15
20
21
26
23
Each month's total comprises the sum of three months' worth of ratings.
FDMT Financial Forecast
FDMT Stock Forecast FAQ
What is FDMT’s average 12-month price target, according to analysts?
Based on analyst ratings, 4D Molecular Therapeutics’s 12-month average price target is $47.00.
What is FDMT’s upside potential, based on the analysts’ average price target?
4D Molecular Therapeutics has 503.34% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is FDMT a Buy, Sell or Hold?
4D Molecular Therapeutics has a consensus rating of Moderate Buy which is based on 9 buy ratings, 1 hold ratings and 1 sell ratings.
What is 4D Molecular Therapeutics’s price target?
The average price target for 4D Molecular Therapeutics is $47.00. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $82.00 ,the lowest forecast is $8.00. The average price target represents 503.34% Increase from the current price of $7.79.
The highest analyst price target is $82.00 ,the lowest forecast is $8.00. The average price target represents 503.34% Increase from the current price of $7.79.
What do analysts say about 4D Molecular Therapeutics?
4D Molecular Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of FDMT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.